Literature DB >> 10652986

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

C N Bassett1, M D Neely, K R Sidell, W R Markesbery, L L Swift, T J Montine.   

Abstract

Brain regional oxidative damage is thought to be a central mechanism in the pathogenesis of Alzheimer's disease (AD). Recent studies of cerebrospinal fluid (CSF) have suggested that increased lipid peroxidation of CSF and CSF lipoproteins also may occur in AD patients. In the present study, we determined the susceptibility of human CSF to ex vivo lipid peroxidation and tested the hypothesis that oxidized CSF lipoproteins may be neurotoxic. Whole CSF or a CSF lipoprotein fraction (d < 1.210 g/mL) was oxidized with 2,2'-azobis(2-amidino-propane)dihydrochloride (AAPH), a hydrophilic free-radical generator. Kinetics of CSF lipid peroxidation were followed by a standard fluorescence product accumulation assay. Oxidation of AD CSF yielded significantly shorter fluorescent lag times than controls, indicating reduced antioxidant capacity. Electrophoretic mobilities of CSF apolipoproteins were specifically reduced upon oxidation of CSF with AAPH, suggesting that lipoproteins are primary targets of CSF lipid peroxidation. Cultured neuronal cells were exposed to physiological concentrations of isolated CSF lipoproteins oxidized with increasing concentrations of AAPH; the resulting neurotoxicity showed a significant linear AAPH concentration-response relationship. These results suggest that oxidized CSF lipoproteins may contribute to the pathogenesis of neurodegeneration in AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10652986     DOI: 10.1007/s11745-999-0478-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  43 in total

Review 1.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

2.  Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides.

Authors:  M Miyata; J D Smith
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

Review 3.  The measurement and mechanism of lipid peroxidation in biological systems.

Authors:  J M Gutteridge; B Halliwell
Journal:  Trends Biochem Sci       Date:  1990-04       Impact factor: 13.807

4.  A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

Authors:  M Sano; C Ernesto; R G Thomas; M R Klauber; K Schafer; M Grundman; P Woodbury; J Growdon; C W Cotman; E Pfeiffer; L S Schneider; L J Thal
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

5.  Dynamics of the oxidation of low density lipoprotein induced by free radicals.

Authors:  N Noguchi; N Gotoh; E Niki
Journal:  Biochim Biophys Acta       Date:  1993-07-01

Review 6.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

7.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

8.  Increased oxidizability of plasma low density lipoprotein from patients with coronary artery disease.

Authors:  H C Chiu; J R Jeng; S M Shieh
Journal:  Biochim Biophys Acta       Date:  1994-01-11

9.  Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde.

Authors:  H F Hoff; J O'Neil
Journal:  J Lipid Res       Date:  1993-07       Impact factor: 5.922

Review 10.  Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease.

Authors:  R W Mahley; B P Nathan; S Bellosta; R E Pitas
Journal:  Curr Opin Lipidol       Date:  1995-04       Impact factor: 4.776

View more
  17 in total

1.  Human, but not bovine, oxidized cerebral spinal fluid lipoproteins disrupt neuronal microtubules.

Authors:  M D Neely; L L Swift; T J Montine
Journal:  Lipids       Date:  2000-11       Impact factor: 1.880

2.  Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein.

Authors:  Anthony R White; Gerd Multhaup; Denise Galatis; William J McKinstry; Michael W Parker; Rüdiger Pipkorn; Konrad Beyreuther; Colin L Masters; Roberto Cappai
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

3.  Membrane-mediated amyloidogenesis and the promotion of oxidative lipid damage by amyloid beta proteins.

Authors:  Ian V J Murray; Liu Liu; Hiroaki Komatsu; Kunihiro Uryu; Gang Xiao; John A Lawson; Paul H Axelsen
Journal:  J Biol Chem       Date:  2007-01-24       Impact factor: 5.157

4.  Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.

Authors:  Sönke Arlt; Tomas Müller-Thomsen; Ulrike Beisiegel; Anatol Kontush
Journal:  Neurochem Res       Date:  2012-08-10       Impact factor: 3.996

5.  Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease.

Authors:  Yue Yang; C Dirk Keene; Elaine R Peskind; Douglas R Galasko; Shu-Ching Hu; Eiron Cudaback; Angela M Wilson; Ge Li; Chang-En Yu; Kathleen S Montine; Jing Zhang; Geoffrey S Baird; Bradley T Hyman; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2015-07       Impact factor: 3.685

6.  Lysophosphatidic acid induces increased BACE1 expression and Aβ formation.

Authors:  Jing Shi; Yunzhou Dong; Mei-Zhen Cui; Xuemin Xu
Journal:  Biochim Biophys Acta       Date:  2012-10-02

7.  Oxidized lipoproteins, beta amyloid peptides and Alzheimer's disease.

Authors:  A Y Sun; B Draczynska-Lusiak; G Y Sun
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

8.  Amyloid Plaque-Associated Oxidative Degradation of Uniformly Radiolabeled Arachidonic Acid.

Authors:  Ran Furman; Ian V J Murray; Hayley E Schall; Qiwei Liu; Yonatan Ghiwot; Paul H Axelsen
Journal:  ACS Chem Neurosci       Date:  2016-02-09       Impact factor: 4.418

9.  Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion.

Authors:  Feng-Shiun Shie; M Diana Neely; Izumi Maezawa; Hope Wu; Sandy J Olson; Günther Jürgens; Kathleen S Montine; Thomas J Montine
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

Review 10.  Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.

Authors:  Sunil S Adav; Siu Kwan Sze
Journal:  Mol Brain       Date:  2016-11-03       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.